Skip to main content
Erschienen in: Virchows Archiv 5/2015

01.05.2015 | Original Article

Expression of proteins associated with hypoxia and Wnt pathway activation is of prognostic significance in hepatocellular carcinoma

verfasst von: Supriya Srivastava, Bhavin Thakkar, Khay Guan Yeoh, Khek Yu Ho, Ming Teh, Richie Soong, Manuel Salto-Tellez

Erschienen in: Virchows Archiv | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

In the development and progression of hepatocellular carcinoma, tumor hypoxia plays an important role, as does activation of the Wnt pathway. The aim of this study was to characterize the expression and interrelationship between hypoxia and Wnt-pathway-associated proteins as prognostic factors for hepatocellular carcinoma. Expression of HIF-1α, CA-IX, E-cadherin, β-catenin, and Ki-67 was assessed by immunohistochemistry in 179 primary hepatocellular carcinoma cases. Univariate and multivariate analyses were performed to assess the relationship between the clinicopathological factors, protein expression, overall survival (OS), and recurrence-free survival (RFS). By univariate analysis, tumor stage, size, satellitosis, and vascular invasion were confirmed as prognostic factors for worse OS and RFS. High expression of HIF-1α, CA-IX, β-catenin, Ki-67, and E-cadherin was observed in 60, 15, 64, 8, and 64 % of tumors, respectively, and this was significantly associated with poor OS. CA-IX, HIF-1α, and E-cadherin were independent predictors of poor prognosis. We stratified 169 patients into four groups according to the expression level of hypoxia and Wnt pathway markers. The group with high expression of both hypoxia and Wnt-pathway-associated proteins showed worst OS. The poor survival of this group was also significant in patients with early stage disease and tumor size of less than 5 cm (p < 0.05). We identified a subgroup of hepatocellular carcinoma patients with high expression of both hypoxia and Wnt pathway proteins and found this predictive of poor survival. The therapeutic options for this group might need to be revisited.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (2013) SEER Cancer Statistics Review, 1975–2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (2013) SEER Cancer Statistics Review, 1975–2011, National Cancer Institute. Bethesda, MD, http://​seer.​cancer.​gov/​csr/​1975_​2011/​, based on November 2013 SEER data submission, posted to the SEER web site, April 2014
2.
Zurück zum Zitat D’Amico G, Garcia-Tsao G, Pagliaro L (2006) Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 44:217e31 D’Amico G, Garcia-Tsao G, Pagliaro L (2006) Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 44:217e31
3.
Zurück zum Zitat Tsochatzis EA, Bosch J, Burroughs AK (2014) Liver cirrhosis. Lancet 17:1749e61 Tsochatzis EA, Bosch J, Burroughs AK (2014) Liver cirrhosis. Lancet 17:1749e61
4.
Zurück zum Zitat Chen XP, Qiu FZ, Wu ZD, Zhang ZW, Huang ZY, Chen YF (2006) Long term outcome of resection of large hepatocellular carcinoma. Br J Surg 93(5):600–606CrossRefPubMed Chen XP, Qiu FZ, Wu ZD, Zhang ZW, Huang ZY, Chen YF (2006) Long term outcome of resection of large hepatocellular carcinoma. Br J Surg 93(5):600–606CrossRefPubMed
5.
Zurück zum Zitat Vakili K, Pomposelli JJ, Cheah YL et al (2009) Living donor liver transplantation for hepatocellular carcinoma: increased recurrence but improved survival. Liver Transpl 15:1861–1866CrossRefPubMed Vakili K, Pomposelli JJ, Cheah YL et al (2009) Living donor liver transplantation for hepatocellular carcinoma: increased recurrence but improved survival. Liver Transpl 15:1861–1866CrossRefPubMed
6.
Zurück zum Zitat Sangiovanni A, Prati GM, Fasani P, Ronchi G, Romeo R, Manini M et al (2006) The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients. Hepatology 43:1303e10CrossRef Sangiovanni A, Prati GM, Fasani P, Ronchi G, Romeo R, Manini M et al (2006) The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients. Hepatology 43:1303e10CrossRef
7.
Zurück zum Zitat Lim HY, Sohn I, Deng S, Lee J, Jung SH, Mao M, Xu J, Wang K, Shi S, Joh JW, Choi YL, Park CK (2013) Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling. Ann Surg Oncol 20(12):3747–3753CrossRefPubMed Lim HY, Sohn I, Deng S, Lee J, Jung SH, Mao M, Xu J, Wang K, Shi S, Joh JW, Choi YL, Park CK (2013) Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling. Ann Surg Oncol 20(12):3747–3753CrossRefPubMed
8.
Zurück zum Zitat Pang RW, Poon RT (2007) From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now. Oncology 72:30–44CrossRefPubMed Pang RW, Poon RT (2007) From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now. Oncology 72:30–44CrossRefPubMed
9.
Zurück zum Zitat Villanueva A, Newell P, Chiang DY, Friedman SL, Llovet JM (2007) Genomics and signaling pathways in hepatocellular carcinoma. Semin Liver Dis 27:55–76CrossRefPubMed Villanueva A, Newell P, Chiang DY, Friedman SL, Llovet JM (2007) Genomics and signaling pathways in hepatocellular carcinoma. Semin Liver Dis 27:55–76CrossRefPubMed
10.
Zurück zum Zitat Gwak GY, Yoon JH, Kim KM, Lee HS, Chung JW, Gores GJ (2005) Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression. J Hepatol 42:358–64CrossRefPubMed Gwak GY, Yoon JH, Kim KM, Lee HS, Chung JW, Gores GJ (2005) Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression. J Hepatol 42:358–64CrossRefPubMed
11.
Zurück zum Zitat Gort EH, Groot AJ, van der Wall E, van Diest PJ, Vooijs MA (2008) Hypoxic regulation of metastasis via hypoxia-inducible factors. Curr Mol Med 8:60–67CrossRefPubMed Gort EH, Groot AJ, van der Wall E, van Diest PJ, Vooijs MA (2008) Hypoxic regulation of metastasis via hypoxia-inducible factors. Curr Mol Med 8:60–67CrossRefPubMed
12.
Zurück zum Zitat Barsoum IB, Smallwood CA, Siemens DR, Graham CH (2014) A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells. Cancer Res 74(3):665–6674CrossRefPubMed Barsoum IB, Smallwood CA, Siemens DR, Graham CH (2014) A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells. Cancer Res 74(3):665–6674CrossRefPubMed
14.
Zurück zum Zitat Xie H, Song J, Liu K et al (2008) The expression of hypoxia-inducible factor-1α in hepatitis B virus-related hepatocellular carcinoma: correlation with patients’ prognosis and hepatitis B virus X protein. Dig Dis Sci 53:3225–3233CrossRefPubMed Xie H, Song J, Liu K et al (2008) The expression of hypoxia-inducible factor-1α in hepatitis B virus-related hepatocellular carcinoma: correlation with patients’ prognosis and hepatitis B virus X protein. Dig Dis Sci 53:3225–3233CrossRefPubMed
15.
Zurück zum Zitat Pastorekova S, Ratcliffe PJ, Pastorek J (2008) Molecular mechanisms of carbonic anhydrase IX-mediated pH regulation under hypoxia. BJU Int 101:8–15CrossRefPubMed Pastorekova S, Ratcliffe PJ, Pastorek J (2008) Molecular mechanisms of carbonic anhydrase IX-mediated pH regulation under hypoxia. BJU Int 101:8–15CrossRefPubMed
16.
Zurück zum Zitat Pastorekova S, Zatovicova M, Pastorek J (2008) Cancer-associated carbonic anhydrases and their inhibition. Curr Pharm Des 14:685–98CrossRefPubMed Pastorekova S, Zatovicova M, Pastorek J (2008) Cancer-associated carbonic anhydrases and their inhibition. Curr Pharm Des 14:685–98CrossRefPubMed
17.
Zurück zum Zitat Swinson DEB, Jones JL, Richardson D et al (2003) Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in Non-small-cell lung cancer. J Clin Oncol 21:473–482CrossRefPubMed Swinson DEB, Jones JL, Richardson D et al (2003) Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in Non-small-cell lung cancer. J Clin Oncol 21:473–482CrossRefPubMed
18.
Zurück zum Zitat Beasley NJ, Wykoff CC, Watson PH et al (2001) Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. Cancer Res 61:5262–5267PubMed Beasley NJ, Wykoff CC, Watson PH et al (2001) Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. Cancer Res 61:5262–5267PubMed
19.
Zurück zum Zitat Su-jong Y, Yoon J-h, Lee J-h et al (2011) Inhibition of hypoxia-inducible carbonic anhydrase-IX enhances hexokinase II inhibitor-induced hepatocellular carcinoma cell apoptosis. Acta Pharmacol Sin 32:912–920CrossRef Su-jong Y, Yoon J-h, Lee J-h et al (2011) Inhibition of hypoxia-inducible carbonic anhydrase-IX enhances hexokinase II inhibitor-induced hepatocellular carcinoma cell apoptosis. Acta Pharmacol Sin 32:912–920CrossRef
20.
Zurück zum Zitat Lim JH, Chun YS, Park JW (2008) Hypoxia-inducible factor-1α obstructs a Wnt signaling pathway by inhibiting the hARD1-mediated activation of β-catenin. Cancer Res 68:5177–5184CrossRefPubMed Lim JH, Chun YS, Park JW (2008) Hypoxia-inducible factor-1α obstructs a Wnt signaling pathway by inhibiting the hARD1-mediated activation of β-catenin. Cancer Res 68:5177–5184CrossRefPubMed
21.
Zurück zum Zitat Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7:462–503CrossRefPubMed Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7:462–503CrossRefPubMed
22.
Zurück zum Zitat Sobin LH, Wittekind C (eds) (2002) UICC (International Union against Cancer) TNM classification of malignant tumors, 6th ed. Wiley, New York, pp 1–264 Sobin LH, Wittekind C (eds) (2002) UICC (International Union against Cancer) TNM classification of malignant tumors, 6th ed. Wiley, New York, pp 1–264
23.
Zurück zum Zitat Llovet JM, Bru C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Disv 19:329e38 Llovet JM, Bru C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Disv 19:329e38
24.
Zurück zum Zitat Das K, Mohd Omar MF, Ong CW et al (2008) TRARESA: tissue microarray-based hospital system for biomarker validation and discovery. Pathology 40:441–449CrossRefPubMed Das K, Mohd Omar MF, Ong CW et al (2008) TRARESA: tissue microarray-based hospital system for biomarker validation and discovery. Pathology 40:441–449CrossRefPubMed
25.
26.
Zurück zum Zitat Guo C, Liu QG, Yang W, Zhang ZL, Yao YM (2008) Relation among p130Cas, E-cadherin and B-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 7:490–496PubMed Guo C, Liu QG, Yang W, Zhang ZL, Yao YM (2008) Relation among p130Cas, E-cadherin and B-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 7:490–496PubMed
27.
Zurück zum Zitat Saarnio J, Parkkila S, Parkkila AK et al (1998) Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation. Am J of Pathol 153:279–285CrossRef Saarnio J, Parkkila S, Parkkila AK et al (1998) Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation. Am J of Pathol 153:279–285CrossRef
28.
Zurück zum Zitat Cho I-R, Koh S-S, Min H-J et al (2010) Down-regulation of HIF-1α by oncolytic reovirus infection independently of VHL and p53. Cancer Gene Ther 17:365–372CrossRefPubMed Cho I-R, Koh S-S, Min H-J et al (2010) Down-regulation of HIF-1α by oncolytic reovirus infection independently of VHL and p53. Cancer Gene Ther 17:365–372CrossRefPubMed
29.
Zurück zum Zitat Zeng G, Apte U, Cieply B, Singh S, Monga SP (2007) siRNA-mediated beta-catenin knockdown in human hepatoma cells results in decreased growth and survival. Neoplasia 9:951–959CrossRefPubMedCentralPubMed Zeng G, Apte U, Cieply B, Singh S, Monga SP (2007) siRNA-mediated beta-catenin knockdown in human hepatoma cells results in decreased growth and survival. Neoplasia 9:951–959CrossRefPubMedCentralPubMed
30.
Zurück zum Zitat Li Y, Lu W, King TD et al (2010) Dkk1 stabilizes Wnt co-receptor LRP6: implication for Wnt ligand-induced LRP6 down-regulation. PLoS One 5:e11014CrossRefPubMedCentralPubMed Li Y, Lu W, King TD et al (2010) Dkk1 stabilizes Wnt co-receptor LRP6: implication for Wnt ligand-induced LRP6 down-regulation. PLoS One 5:e11014CrossRefPubMedCentralPubMed
31.
Zurück zum Zitat Huang SM, Mishina YM, Liu S et al (2009) Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461:614–620CrossRefPubMed Huang SM, Mishina YM, Liu S et al (2009) Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461:614–620CrossRefPubMed
32.
Zurück zum Zitat Kaidi A, Williams AC, Paraskeva C (2007) Interaction between β-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat Cell Biol 9:210–217CrossRefPubMed Kaidi A, Williams AC, Paraskeva C (2007) Interaction between β-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat Cell Biol 9:210–217CrossRefPubMed
33.
Zurück zum Zitat Mazumdar J, O’Brien WT, Johnson RS, LaManna JC, Chavez JC, Klein PS, Simon MC (2010) O2 regulates stem cells through Wnt/β-catenin signalling. Nat Cell Biol 12:1007–1013CrossRefPubMedCentralPubMed Mazumdar J, O’Brien WT, Johnson RS, LaManna JC, Chavez JC, Klein PS, Simon MC (2010) O2 regulates stem cells through Wnt/β-catenin signalling. Nat Cell Biol 12:1007–1013CrossRefPubMedCentralPubMed
34.
Zurück zum Zitat Lehwald N, Tao G-Z, Jang KY et al (2011) Wnt-β-catenin signaling protects against hepatic ischemia and reperfusion injury in mice. Gastroenterol 141:707–718CrossRef Lehwald N, Tao G-Z, Jang KY et al (2011) Wnt-β-catenin signaling protects against hepatic ischemia and reperfusion injury in mice. Gastroenterol 141:707–718CrossRef
35.
Zurück zum Zitat Liu L, Zhu XD, Wang WQ, Sorkin M, Knoefel WT, Sylvester KG (2010) Activation of β-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis. Clin Cancer Res 16:2740–2750CrossRefPubMed Liu L, Zhu XD, Wang WQ, Sorkin M, Knoefel WT, Sylvester KG (2010) Activation of β-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis. Clin Cancer Res 16:2740–2750CrossRefPubMed
36.
Zurück zum Zitat Teicher BA, Liu SD, Liu JT, Holden SA, Herman TS (1993) A carbonic anhydrase inhibitor as a potential modulator of cancer therapies. Anticancer Res 13:1549–1556PubMed Teicher BA, Liu SD, Liu JT, Holden SA, Herman TS (1993) A carbonic anhydrase inhibitor as a potential modulator of cancer therapies. Anticancer Res 13:1549–1556PubMed
37.
Zurück zum Zitat Parkkila S, Rajaniemi H, Parkkila AK et al (2000) Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. Proc Natl Acad Sci 97:2220–2224CrossRefPubMedCentralPubMed Parkkila S, Rajaniemi H, Parkkila AK et al (2000) Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. Proc Natl Acad Sci 97:2220–2224CrossRefPubMedCentralPubMed
38.
Zurück zum Zitat Zatovicova M, Jelenska L, Hulikova A et al (2010) Carbonic anhydrase IX as an anticancer therapy target: preclinical evaluation of internalizing monoclonal antibody directed to catalytic domain. Curr Pharm Des 16(29):3255–3263CrossRefPubMed Zatovicova M, Jelenska L, Hulikova A et al (2010) Carbonic anhydrase IX as an anticancer therapy target: preclinical evaluation of internalizing monoclonal antibody directed to catalytic domain. Curr Pharm Des 16(29):3255–3263CrossRefPubMed
39.
Zurück zum Zitat Lou Y, McDonald PC, Oloumi A et al (2011) Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. Cancer Res 71(9):3364–3376CrossRefPubMed Lou Y, McDonald PC, Oloumi A et al (2011) Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. Cancer Res 71(9):3364–3376CrossRefPubMed
40.
Zurück zum Zitat Wang GL, Jiang B-H, Rue EA, Semenza GL (1995) Hypoxia-inducible factor 1 is a basic-helix–loop–helix–PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci 92:5510–5514CrossRefPubMedCentralPubMed Wang GL, Jiang B-H, Rue EA, Semenza GL (1995) Hypoxia-inducible factor 1 is a basic-helix–loop–helix–PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci 92:5510–5514CrossRefPubMedCentralPubMed
41.
Zurück zum Zitat Wilson GK, Tennant DA, McKeating JA (2014) Hypoxia inducible factors in liver disease and hepatocellular carcinoma: current understanding and future directions. J of Hepatol 61(6):1397–1406CrossRef Wilson GK, Tennant DA, McKeating JA (2014) Hypoxia inducible factors in liver disease and hepatocellular carcinoma: current understanding and future directions. J of Hepatol 61(6):1397–1406CrossRef
42.
Zurück zum Zitat Dai C-X, Gao Q, Qiu S-J et al (2009) Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery. BMC Cancer 9:418CrossRefPubMedCentralPubMed Dai C-X, Gao Q, Qiu S-J et al (2009) Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery. BMC Cancer 9:418CrossRefPubMedCentralPubMed
43.
Zurück zum Zitat Koshiji M, Kageyama Y, Pete EA, Horikawa I, Barrett JC, Huang LE (2004) HIF-1α induces cell cycle arrest by functionally counteracting Myc. EMBO J 23:1949–1956CrossRefPubMedCentralPubMed Koshiji M, Kageyama Y, Pete EA, Horikawa I, Barrett JC, Huang LE (2004) HIF-1α induces cell cycle arrest by functionally counteracting Myc. EMBO J 23:1949–1956CrossRefPubMedCentralPubMed
44.
Zurück zum Zitat Jing SW, Wang YD, Chen LQ et al (2013) Hypoxia suppresses E-cadherin and enhances matrix metalloproteinase-2 expression favoring esophageal carcinoma migration and invasion via hypoxia inducible factor-1 alpha activation. Dis Esophagus 26(1):75–83CrossRefPubMed Jing SW, Wang YD, Chen LQ et al (2013) Hypoxia suppresses E-cadherin and enhances matrix metalloproteinase-2 expression favoring esophageal carcinoma migration and invasion via hypoxia inducible factor-1 alpha activation. Dis Esophagus 26(1):75–83CrossRefPubMed
Metadaten
Titel
Expression of proteins associated with hypoxia and Wnt pathway activation is of prognostic significance in hepatocellular carcinoma
verfasst von
Supriya Srivastava
Bhavin Thakkar
Khay Guan Yeoh
Khek Yu Ho
Ming Teh
Richie Soong
Manuel Salto-Tellez
Publikationsdatum
01.05.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Virchows Archiv / Ausgabe 5/2015
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-015-1745-4

Weitere Artikel der Ausgabe 5/2015

Virchows Archiv 5/2015 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …